BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3545351)

  • 1. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
    Oliva D; Bernini F; Corsini A; Nicosia S
    Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGI2 receptors in vasculature and platelets: 5Z-carbacyclin discriminates between them.
    Nicosia S; Oliva D; Noè MA; Corsini A; Folco GC; Fumagalli R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():474-8. PubMed ID: 2959100
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
    Oliva D; Giovanazzi S; Lograno M; Mongelli N; Corsini A; Fumagalli R; Nicosia S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():172-5. PubMed ID: 2526466
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery.
    Oliva D; Noè A; Nicosia S; Bernini F; Fumagalli R; Whittle BJ; Moncada S; Vane JR
    Eur J Pharmacol; 1984 Oct; 105(3-4):207-13. PubMed ID: 6391937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding to prostaglandin (PG) receptors and activation of adenyl cyclase by 20-isopropylidene-PGS in rabbit platelet membranes.
    Ushiyama S; Handa S; Yamazaki M
    Prostaglandins; 1988 Oct; 36(4):477-89. PubMed ID: 2853419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes.
    Stein JM; Martin BR
    FEBS Lett; 1984 Jan; 165(2):290-2. PubMed ID: 6363123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
    Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature.
    Chaudhari A; Gupta S; Kirschenbaum MA
    Biochim Biophys Acta; 1990 Jul; 1053(2-3):156-61. PubMed ID: 2166584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
    Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
    Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.